Dyadic International (DYAI) Projected to Post Quarterly Earnings on Wednesday

Dyadic International (NASDAQ:DYAI) is expected to post its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect Dyadic International to announce earnings of ($0.04) per share and revenue of $1.60 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Dyadic International Price Performance

Shares of NASDAQ:DYAI opened at $1.37 on Tuesday. The company has a market cap of $40.54 million, a PE ratio of -5.96 and a beta of 0.95. Dyadic International has a fifty-two week low of $0.93 and a fifty-two week high of $2.67. The firm has a 50-day simple moving average of $1.49 and a 200 day simple moving average of $1.42. The company has a quick ratio of 5.15, a current ratio of 5.15 and a debt-to-equity ratio of 1.54.

Hedge Funds Weigh In On Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Bank of America Corp DE boosted its stake in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,132 shares of the biotechnology company’s stock after purchasing an additional 26,965 shares during the quarter. Bank of America Corp DE owned approximately 0.09% of Dyadic International worth $47,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 27.95% of the company’s stock.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.